Tag: NASDAQ:OPXA

Finance

Biotech Losers: Geron Corporation (NASDAQ:GERN), OXiGENE Inc (NASDAQ:OXGN), Opexa Therapeutics Inc (NASDAQ:OPXA), 22nd Century Group Inc (NYSEMKT:XXII)

Brower Piven, A Professional Corporation on Mar. 18 announced that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Geron Corporation (NASDAQ:GERN) securities during the period between June 16, 2013 and March 11, 2014, inclusive (the “Class Period”). Geron Corporation (NASDAQ:GERN) stock performance was -8.06% in last session and finished … Continue reading Biotech Losers: Geron Corporation (NASDAQ:GERN), OXiGENE Inc (NASDAQ:OXGN), Opexa Therapeutics Inc (NASDAQ:OPXA), 22nd Century Group Inc (NYSEMKT:XXII)

Jason Knox
BioTech

Biotech Gainers: Geron Corporation (NASDAQ:GERN), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Opexa Therapeutics Inc. (NASDAQ:OPXA)

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Geron Corporation (NASDAQ:GERN) securities during the period between June 16, 2013 and March 11, 2014, inclusive (the “Class Period”). Geron Corporation (NASDAQ:GERN) stock performance was 39.33% in last session and finished the day at … Continue reading Biotech Gainers: Geron Corporation (NASDAQ:GERN), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Opexa Therapeutics Inc. (NASDAQ:OPXA)

John Bellich
FB Nasdaq FB Facebook
BioTech

Biotech Most Volatile Stocks: Opexa Therapeutics (NASDAQ:OPXA), Intrexon (NYSE:XON), Chimerix (NASDAQ:CMRX), NewLink Genetics (NASDAQ:NLNK)

On March 5, 2014, Opexa Therapeutics, Inc. (NASDAQ:OPXA) entered into a First Amendment to Sales Agreement (the “First Amendment”) with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P.) (the “New Sales Manager”) and Brinson Patrick Securities Corporation (the “Original Sales Manager”). Pursuant to the First Amendment, the Sales Agreement dated September 6, 2012 by and between the Company and … Continue reading Biotech Most Volatile Stocks: Opexa Therapeutics (NASDAQ:OPXA), Intrexon (NYSE:XON), Chimerix (NASDAQ:CMRX), NewLink Genetics (NASDAQ:NLNK)

Colin Pettis